Cronos Group Inc. Common Share earnings per share and revenue
On Nov 06, 2025, CRON reported earnings of 0.08 USD per share (EPS) for Q3 25, Inline the estimate of 0.00 USD, resulting in a 0.00% surprise. Revenue reached 36.34 million, compared to an expected 38.05 million, with a -4.49% difference. The market reacted with a +0.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.01 USD, with revenue projected to reach 40.12 million USD, implying an decrease of -87.50% EPS, and increase of 10.40% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Cronos Group Inc. Common Share's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cronos Group Inc. Common Share reported EPS of $0.08, missing estimates by 0%, and revenue of $36.34M, -4.49% below expectations.
How did the market react to Cronos Group Inc. Common Share's Q3 2025 earnings?
The stock price moved up 0.82%, changed from $2.45 before the earnings release to $2.47 the day after.
When is Cronos Group Inc. Common Share expected to report next?
The next earning report is scheduled for Mar 03, 2026.
What are the forecasts for Cronos Group Inc. Common Share's next earnings report?
Based on 3
analysts, Cronos Group Inc. Common Share is expected to report EPS of $0.01 and revenue of $40.12M for Q4 2025.